chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: After my first shot, I started having ringing in my ear, especially when I lay down.  It has continued since my second shot on April 9, 2021; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on an unknown date in 2021 and also second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on 09Apr2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Concomitant medications included levothyroxine .075 mcg daily (MANUFACTURER UNKNOWN) for unspecified indication and unknown start date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021, after first dose, the patient experienced ringing in the ear, especially when lay down. It had continued since the second shot which had taken on 09Apr2021. The patient did not receive any treatment for the event. The clinical outcome of the event ringing in the ear was not recovered, at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Chills, Feeling abnormal, Nausea, Pain
Clinical narrative: slight nausea; "brain fog" (like a disconnect with her thinking and speech); "brain fog" (like a disconnect with her thinking and speech); aches; chills; This is a spontaneous report from a non-contactable consumer, the parent. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 10:00 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included unspecified birth control medications from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have any allergies to medications, food or other products. On 10Apr2021 at 17:00, the patient experienced "brain fog" (like a disconnect with thinking and speech) in approximately 8 hours after shot and under 12 hours the patient had some aches and chills, took a tylenol and went to bed. On 11Apr2021, patient woke up next morning with aches/chills which lingered through part of day and also reported some slight nausea morning after shot and took tylenol a day in the morning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the aches, chills which included treatment with tylenol and hot shower. The clinical outcomes of the events  "brain fog" (like a disconnect with her thinking and speech), aches, chills and slight nausea was recovered on an unknown date of Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dyspepsia, Fatigue, Hot flush
Clinical narrative: Severe weakness and fatigue; Severe weakness and fatigue; nausea and burning stomache; nausea and burning stomache; Migraine; excessive thirst and urination; excessive thirst and urination; chills and hot flashes; chills and hot flashes; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease, reactive airways disease (RAD) and hashimoto's. The patient previously took venlafaxine hydrochloride (EFFEXOR), nortriptyline (MANUFACTURER UNKNOWN) and metaxalone (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications taken within two weeks of vaccination included naproxen (MANUFACTURER UNKNOWN), diazepam (MANUFACTURER UNKNOWN), oxycodone (MANUFACTURER UNKNOWN), galcanezumab gnlm (EMGALITY) and rizatriptan (MANUFACTURER UNKNOWN) all from unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 at 14:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 03:00, the patient experienced severe weakness and fatigue, nausea and burning stomache, migraine, excessive thirst and urination, chills and hot flashes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe weakness and fatigue, nausea and burning stomache, migraine, excessive thirst and urination, chills and hot flashes was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Pollakiuria, Thirst
Clinical narrative: Severe weakness and fatigue; Severe weakness and fatigue; nausea and burning stomache; nausea and burning stomache; Migraine; excessive thirst and urination; excessive thirst and urination; chills and hot flashes; chills and hot flashes; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease, reactive airways disease (RAD) and hashimoto's. The patient previously took venlafaxine hydrochloride (EFFEXOR), nortriptyline (MANUFACTURER UNKNOWN) and metaxalone (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications taken within two weeks of vaccination included naproxen (MANUFACTURER UNKNOWN), diazepam (MANUFACTURER UNKNOWN), oxycodone (MANUFACTURER UNKNOWN), galcanezumab gnlm (EMGALITY) and rizatriptan (MANUFACTURER UNKNOWN) all from unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 at 14:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 03:00, the patient experienced severe weakness and fatigue, nausea and burning stomache, migraine, excessive thirst and urination, chills and hot flashes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe weakness and fatigue, nausea and burning stomache, migraine, excessive thirst and urination, chills and hot flashes was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Lymphadenopathy
Clinical narrative: Severe Headache that will not go away; Joint pain; Dizziness; Swollen lymph node; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Apr2021 at 10:00 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) and lithium (MANUFACTURER UNKNOWN) both for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced severe headache that did not go away, joint pain, dizziness and swollen lymph node. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events. The clinical outcome of the events severe headache that did not go away, joint pain, dizziness and swollen lymph node was not resolved, at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Headache, Pain
Clinical narrative: Woke up with chills; intense body aches for more than 12 hours; bad headache; Had fever over 102; lightheaded; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 11:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medications included IC nitrofurantoin mono-mcr (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 12:15, the patient woke up with chills, intense body aches and bad headache. The patient also had fever over 102 and lightheaded . Fever over 102 and body aches was there for more than 12 hours, headache and lightheaded was still there 2 days later. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL) which gave her a little relief . The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense body aches, bad headache was recovered on 11Apr2021; while that of woke up with chills, light headed and fever over 102 were resolved on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Woke up with chills; intense body aches for more than 12 hours; bad headache; Had fever over 102; lightheaded; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 11:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. Concomitant medications included IC nitrofurantoin mono-mcr (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 12:15, the patient woke up with chills, intense body aches and bad headache. The patient also had fever over 102 and lightheaded . Fever over 102 and body aches was there for more than 12 hours, headache and lightheaded was still there 2 days later. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL) which gave her a little relief . The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense body aches, bad headache was recovered on 11Apr2021; while that of woke up with chills, light headed and fever over 102 were resolved on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Chills, Headache, Nausea
Clinical narrative: Covid like symptoms; nausea; chills; fever; headache; body ache; loss of taste; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 38-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 16Apr2021 10:30 (at the age of 38-year-old) at dose 1, single for covid-19 immunisation. Medical history included covid-19 (if covid prior Vaccination: Yes). Patient had Known allergies with Codeine. Patient did not have other vaccine in four weeks, other medications in two weeks. Concomitant medications were not reported. On 16Apr2021 22:30 the patient experienced Covid like symptoms including nausea, chills, fever, headache, chills, body ache and loss of taste. The patient underwent lab tests and procedures which included Nasal Swab (Covid test type post vaccination), SARS covid 19 (Covid test name post vaccination): negative on 16Apr2021. It was unknown whether the patient received treatment for the adverse events. Outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Covid like symptoms; nausea; chills; fever; headache; body ache; loss of taste; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 38-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm right on 16Apr2021 10:30 (at the age of 38-year-old) at dose 1, single for covid-19 immunisation. Medical history included covid-19 (if covid prior Vaccination: Yes). Patient had Known allergies with Codeine. Patient did not have other vaccine in four weeks, other medications in two weeks. Concomitant medications were not reported. On 16Apr2021 22:30 the patient experienced Covid like symptoms including nausea, chills, fever, headache, chills, body ache and loss of taste. The patient underwent lab tests and procedures which included Nasal Swab (Covid test type post vaccination), SARS covid 19 (Covid test name post vaccination): negative on 16Apr2021. It was unknown whether the patient received treatment for the adverse events. Outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 21-years-old) as a single dose for COVID-19 immunization. Medical history included autism, multiple severe allergies, penicillin allergy and pecans (food) allergy. Concomitant medications included levocabastine hydrochloride (ZYRTEC), cyproheptadine (MANUFACTURER UNKNOWN) and montelukast sodium (SINGULAIR) for an unknow indication since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 15:45, the patient experienced itchy rash on chest and back. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of event and included treatment with Benadryl and multiple doses steroid cream started from an unknown date. The clinical outcome of the event itchy rash on chest and back was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, Nervousness
Clinical narrative: I had extreme pain that started on the right side of my abdomen; the pain moved to the middle & lower right side of my back.  The pain lasted about a week; I was nervous to go to Er; This is a spontaneous report from a contactable consumer or other non hcp.     A 49-years-old female patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: ER 7533)), dose 1 via an unspecified route of administration, administered in Arm Left on 01Apr2021 08:30 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant was not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient diagnosed with COVID. Post vaccination patient did not test for COVID. The patient had not known allergies. It was Reported that, the patient experienced had extreme pain that started on the right side of my abdomen on the pain lasted about a week and also Nervousness on 02Apr2021 with outcome of recovered.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Migraine
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER2613), at the age of 61, via an unspecified route of administration, left arm, Mar 31, 2021, at 08:00, single dose, for COVID-19 immunisation. Medical history included post-menopausal. Concomitant medications included estradiol, hydrochlorothiazide and vitamins, all from unknown date for unknown indication. The patient previously took morphine and experienced drug allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 31, 2021, at 17:00, patient experienced migraine (the night post-injection), lingering headaches, sporadic dizziness and easily fatigued. No therapeutic measures taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The outcome of migraine (the night post-injection), lingering headaches, sporadic dizziness and easily fatigued: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm pain for 7 days.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to dust, pollen, mold and dairy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced arm pain for 7 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm pain for 7 days was recovered on 15Apr2021 after a duration of 7 days.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Lymphadenopathy, Vertigo
Clinical narrative: Dizzy; Vertigo; Major lymph node swelling; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced dizzy, major lymph node swelling, vertigo.  It had been a week. The clinical outcome of the event dizzy, major lymph node swelling, vertigo was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Swollen lymph nodes under right arm (the injection arm); Headache; Low-grade fever; Fatigue; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 06Apr2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypoxia, fatty liver, type 2 diabetes mellitus, spasmodic dysphonia, seborrheic dermatitis, hypertension, sulfonamide allergy, allergy to nuts (Walnut), spice allergy (Cinnamon), topical adhesive allergy (Adhesives). Concomitant medications were not reported. The patient previously took morphine (MANUFACTURER UNKNOWN) from an unknown for an unspecified indication and experienced drug allergy. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 16Mar2021 at 14:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 22:00, the patient experienced swollen lymph nodes under right arm; the injection arm, headache, low-grade fever, fatigue, muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events swollen lymph nodes under right arm; the injection arm, headache, low-grade fever, fatigue, muscle aches recovered on an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever so far up to 101.1; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 15Apr2021 at 17:15(at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. Concomitant medications included fluoxetine hydrochloride (PROZAC) from an unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 14:00, the patient experienced fever so far up to 101.1. Therapeutic measures were not taken as a result of the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 16Apr2021, the patient underwent body temperature and the test result was 101.1(unspecified units). The clinical outcome of the event fever so far up to 101.1 was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Eye swelling, Hypertension, Pain, SARS-CoV-2 test
Clinical narrative: Higher blood pressure; Body aches; extreme swelling of left eye; bruising; This is a spontaneous report from a contactable consumer. A 34-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in right arm on 02Apr2021 at 16:15 (at the of 34-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included metoprolol succinate (TOPROL), metformin (METFORMIN), metoprolol (METOPROLOL) and escitalopram oxalate (LEXAPRO) taken for an unspecified indication, start and stop date were not reported other medications in two weeks. The patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No COVID prior vaccination. Facility type vaccine at Doctor's office/urgent care. On 15Apr2021 at 16:30, the patient experienced higher blood pressure, body aches, extreme swelling of left eye and bruising. The patient underwent lab tests and procedures which included SARS-CoV-2 test: (Nasal Swab) negative on 16Apr2021. Adverse event treatment include Antibiotics. The outcome of the events were not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Vaccination site pain
Clinical narrative: Fatigue; Chills; Pain at the injection site; Swollen/enlarged lymph nodes on the top of the shoulder; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 12Apr2021 at 09:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced fatigue, chills, pain at the injection site, swollen/enlarged lymph nodes on the top of the shoulder. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue, chills, pain at the injection site, swollen/enlarged lymph nodes on the top of the shoulder was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure measurement, Chest discomfort, Chest pain, Facial pain
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 48-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8732), via an unspecified route of administration (at the age of 48-years), administered in arm right on 10Apr2021 at 17:30 as dose 1, single for COVID-19 immunization. Medical history included primary immune deficiency, cvid, lyme and other tick borne diseases, mold toxicity, chronic sinusitis and known allergies food sensitivities, Igg infusions, anti-histamines, some antibiotics from an unknown date and unknown if ongoing. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), aloe spp. leaf, althaea officinalis root, herbal nos, magnesium oxide, rheum spp. root, ulmus rubra bark (COLONMAX), fish oil (FISH OIL), vitamin d3 (VITAMIN D3), calcium ascorbate (VITAMIN C [CALCIUM ASCORBATE]), vitamin b [vitamin b nos] (VITAMIN B [VITAMIN B NOS]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. Patient has not been diagnosed with covid prior vaccination and had not been tested for covid post vaccination. On 11Apr2021 at 09:00, the patient experienced swollen right hand with numbness, severe headache with severe light sensitivity, weak legs and arms, racing heart/palpitation, high blood pressure, chest pains, swollen lymph nodes pressing on ear drum, extreme fatigue, low grade fever, face pain, stabbing pains in legs, arms and ribcage, weird feeling in chest. The treatment was received for all the adverse events. No treatment other than anxiety medication. The adverse events resulted in emergency room and physician office visit. The patient underwent lab tests and procedures which included blood pressure measurement: high on Apr2021. The clinical outcome for the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hypertension, Lymphadenopathy, Musculoskeletal chest pain
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 48-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8732), via an unspecified route of administration (at the age of 48-years), administered in arm right on 10Apr2021 at 17:30 as dose 1, single for COVID-19 immunization. Medical history included primary immune deficiency, cvid, lyme and other tick borne diseases, mold toxicity, chronic sinusitis and known allergies food sensitivities, Igg infusions, anti-histamines, some antibiotics from an unknown date and unknown if ongoing. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), aloe spp. leaf, althaea officinalis root, herbal nos, magnesium oxide, rheum spp. root, ulmus rubra bark (COLONMAX), fish oil (FISH OIL), vitamin d3 (VITAMIN D3), calcium ascorbate (VITAMIN C [CALCIUM ASCORBATE]), vitamin b [vitamin b nos] (VITAMIN B [VITAMIN B NOS]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. Patient has not been diagnosed with covid prior vaccination and had not been tested for covid post vaccination. On 11Apr2021 at 09:00, the patient experienced swollen right hand with numbness, severe headache with severe light sensitivity, weak legs and arms, racing heart/palpitation, high blood pressure, chest pains, swollen lymph nodes pressing on ear drum, extreme fatigue, low grade fever, face pain, stabbing pains in legs, arms and ribcage, weird feeling in chest. The treatment was received for all the adverse events. No treatment other than anxiety medication. The adverse events resulted in emergency room and physician office visit. The patient underwent lab tests and procedures which included blood pressure measurement: high on Apr2021. The clinical outcome for the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations, Peripheral swelling, Photophobia, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 48-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8732), via an unspecified route of administration (at the age of 48-years), administered in arm right on 10Apr2021 at 17:30 as dose 1, single for COVID-19 immunization. Medical history included primary immune deficiency, cvid, lyme and other tick borne diseases, mold toxicity, chronic sinusitis and known allergies food sensitivities, Igg infusions, anti-histamines, some antibiotics from an unknown date and unknown if ongoing. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), aloe spp. leaf, althaea officinalis root, herbal nos, magnesium oxide, rheum spp. root, ulmus rubra bark (COLONMAX), fish oil (FISH OIL), vitamin d3 (VITAMIN D3), calcium ascorbate (VITAMIN C [CALCIUM ASCORBATE]), vitamin b [vitamin b nos] (VITAMIN B [VITAMIN B NOS]) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. Patient has not been diagnosed with covid prior vaccination and had not been tested for covid post vaccination. On 11Apr2021 at 09:00, the patient experienced swollen right hand with numbness, severe headache with severe light sensitivity, weak legs and arms, racing heart/palpitation, high blood pressure, chest pains, swollen lymph nodes pressing on ear drum, extreme fatigue, low grade fever, face pain, stabbing pains in legs, arms and ribcage, weird feeling in chest. The treatment was received for all the adverse events. No treatment other than anxiety medication. The adverse events resulted in emergency room and physician office visit. The patient underwent lab tests and procedures which included blood pressure measurement: high on Apr2021. The clinical outcome for the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Fatigue, Hordeolum, Insomnia, Lethargy
Clinical narrative: Less than 36 hours post receiving vaccine left eye started feeling swollen.; Later realized had a stye. Ive never in life had one before. Maybe just a coincidence but unsure.; 72 hours post receiving vaccinefeeling so lethargic; 72 hours post receiving vaccinefeeling so lethargic and exhausted; could hardly function, yet at the sametike had great difficulty falling asleep.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 14:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Mar2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 21:00, the patient experienced less than 36 hours post receiving vaccine left eye started feeling swollen, later realized had a stye. Never in her life she had one before. Maybe just it was a coincidence but unsure. On an unknown date in Apr2021, the patient experienced 72 hours post receiving vaccine felt so lethargic and exhausted, could hardly function, yet at the same time had great difficulty falling asleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 05Apr2021, the patient underwent COVID-19 virus test (Nasal Swab) and the result was negative. The clinical outcome of the events left eye started feeling swollen, later realized had a stye, felt so lethargic and exhausted, could hardly function, yet at the same time had great difficulty falling asleep was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Less than 36 hours post receiving vaccine left eye started feeling swollen.; Later realized had a stye. Ive never in life had one before. Maybe just a coincidence but unsure.; 72 hours post receiving vaccinefeeling so lethargic; 72 hours post receiving vaccinefeeling so lethargic and exhausted; could hardly function, yet at the sametike had great difficulty falling asleep.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 14:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia and penicillin allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Mar2021 at 13:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 21:00, the patient experienced less than 36 hours post receiving vaccine left eye started feeling swollen, later realized had a stye. Never in her life she had one before. Maybe just it was a coincidence but unsure. On an unknown date in Apr2021, the patient experienced 72 hours post receiving vaccine felt so lethargic and exhausted, could hardly function, yet at the same time had great difficulty falling asleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 05Apr2021, the patient underwent COVID-19 virus test (Nasal Swab) and the result was negative. The clinical outcome of the events left eye started feeling swollen, later realized had a stye, felt so lethargic and exhausted, could hardly function, yet at the same time had great difficulty falling asleep was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Acne, Vaccination site pain
Clinical narrative: Forehead acne breakout for 72 hours.; Sore deltoid (location of injection); This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Apr2021 at 15:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. The patient did not have any allergies to food, medications, or other products. The patient's past drugs were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) for an unknown indication since an unknown date. On 12Apr2021 at 04:00, the patient experienced sore deltoid (location of injection) and forehead acne breakout. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event forehead acne breakout for 72 hours was resolved on 15Apr2021 and that of the event sore deltoid (location of injection) was resolved on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Chills; Fever; Headache; Body aches; Pain and swelling near my collarbone; Pain and swelling near my collarbone; Supraclavicular lymphadenopathy; This is a spontaneous report from a contactable consumer, the patient. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the right arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known seasonal allergies. The patient did not receive any other medications in two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, within the first 36 hours of the second dose, the patient experienced typical adverse effects of chills, fever, headache and body aches. Around 48 hours, the patient began feeling a pain and swelling near the collarbone which the patient soon realized was a supraclavicular lymphadenopathy. This occurred on the same side of the injection in the right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, headache, body aches, pain and swelling near collarbone and supraclavicular lymphadenopathy were not resolved at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Chills; Fever; Headache; Body aches; Pain and swelling near my collarbone; Pain and swelling near my collarbone; Supraclavicular lymphadenopathy; This is a spontaneous report from a contactable consumer, the patient. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the right arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known seasonal allergies. The patient did not receive any other medications in two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, within the first 36 hours of the second dose, the patient experienced typical adverse effects of chills, fever, headache and body aches. Around 48 hours, the patient began feeling a pain and swelling near the collarbone which the patient soon realized was a supraclavicular lymphadenopathy. This occurred on the same side of the injection in the right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, headache, body aches, pain and swelling near collarbone and supraclavicular lymphadenopathy were not resolved at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Pain in left arm; Muscle pain; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), theanine (L-THEANINE) and multi-vitamin (MANUFACTURER UNKNOWN) for unknown indication from an unknown start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 15:00 the patient experienced pain in left arm and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain in left arm and muscle pain was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.